Hematology-American Society of Hematology Education Program

Papers
(The H4-Index of Hematology-American Society of Hematology Education Program is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Managing toxicities of Bruton tyrosine kinase inhibitors75
Therapeutic development and current uses of BCL-2 inhibition61
Bispecifics, trispecifics, and other novel immune treatments in myeloma37
Managing toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitors36
Platelet transfusion refractoriness: how do I diagnose and manage?35
Updates in infection risk and management in acute leukemia34
Preventing infections in children and adults with asplenia33
Monoclonal gammopathies of clinical significance32
Management of AL amyloidosis in 202031
Therapy for lower-risk MDS30
Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes29
Next-generation cell therapies: the emerging role of CAR-NK cells25
Inferior vena cava filters: a framework for evidence-based use25
Gene therapy for hemophilia24
Updates in chronic graft-versus-host disease23
Management of Waldenström macroglobulinemia in 202023
Evidence-Based Minireview: Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review22
Have we reached a molecular era in myelodysplastic syndromes?22
Future of CAR T cells in multiple myeloma21
Outpatient transfusions for myelodysplastic syndromes21
Advances in the management of α-thalassemia major: reasons to be optimistic20
“TEG talk”: expanding clinical roles for thromboelastography and rotational thromboelastometry20
Preventing and monitoring for tumor lysis syndrome and other toxicities of venetoclax during treatment of chronic lymphocytic leukemia20
Does ABO and RhD matching matter for platelet transfusion?20
0.026395082473755